|
?:authorAffiliation
|
-
[\'Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.\', \'Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, MA 02118, USA.\', \'Department of Pathology, Brigham and Women\'s Hospital, Boston, MA 02115, USA.\', \'Center for Clinical Investigation, Brigham and Women\'s Hospital, Boston, MA 02115, USA.\', \'Division of Infectious Diseases, Department of Medicine, Brigham and Women\'s Hospital, Boston, MA 02115, USA.\', \'Division of Infectious Diseases, Department of Medicine, Centre Hospitalier de l\'Université de Montréal, Montreal QC H2X 0C1, Canada.\', \'Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.\', \'Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.\', \'Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA 02215, USA.\', \'Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.\', \'AbbVie Bioresearch Center, Worcester, MA 01605, USA.\', \'Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA.\', \'Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}